Ken Griffin Repare Therapeutics Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 300 shares of RPTX stock, worth $843. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300

Previous 1,700 82.35%

Holding current value

$843

Previous $5,000 80.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.75 - $3.99 $103,127 - $149,628	-37,501 Reduced 26.72%	102,860 $353,000
Q2 2024 Aug 14, 2024	BUY	$3.02 - $4.7 $222,845 - $346,813	73,790 Added 110.84%	140,361 $463,000
Q1 2024 May 15, 2024	BUY	$4.53 - $8.41 $90,350 - $167,737	19,945 Added 42.78%	66,571 $313,000
Q4 2023 Feb 14, 2024	SELL	$3.22 - $11.79 $232,609 - $851,697	-72,239 Reduced 60.77%	46,626 $340,000
Q3 2023 Nov 14, 2023	SELL	$8.16 - $13.01 $781,426 - $1.25 Million	-95,763 Reduced 44.62%	118,865 $1.44 Million
Q2 2023 Aug 14, 2023	BUY	$8.63 - $12.53 $1.77 Million - $2.57 Million	204,970 Added 2122.28%	214,628 $2.27 Million
Q1 2023 May 15, 2023	SELL	$9.32 - $15.06 $1.7 Million - $2.75 Million	-182,820 Reduced 94.98%	9,658 $95,000
Q4 2022 Feb 14, 2023	SELL	$12.5 - $18.13 $1.51 Million - $2.19 Million	-120,798 Reduced 38.56%	192,478 $2.83 Million
Q3 2022 Nov 14, 2022	BUY	$11.57 - $15.59 $1.99 Million - $2.69 Million	172,256 Added 122.15%	313,276 $3.8 Million
Q2 2022 Aug 15, 2022	BUY	$8.45 - $14.84 $693,685 - $1.22 Million	82,093 Added 139.31%	141,020 $1.97 Million
Q1 2022 May 16, 2022	SELL	$11.38 - $21.88 $64,706 - $124,409	-5,686 Reduced 8.8%	58,927 $839,000
Q4 2021 Feb 14, 2022	SELL	$19.66 - $28.11 $28,231 - $40,365	-1,436 Reduced 2.17%	64,613 $1.36 Million
Q3 2021 Nov 15, 2021	SELL	$25.71 - $35.24 $3.87 Million - $5.31 Million	-150,651 Reduced 69.52%	66,049 $1.73 Million
Q2 2021 Aug 16, 2021	BUY	$30.1 - $34.85 $5.55 Million - $6.43 Million	184,378 Added 570.44%	216,700 $6.76 Million
Q1 2021 May 17, 2021	BUY	$25.89 - $44.46 $537,735 - $923,434	20,770 Added 179.8%	32,322 $992,000
Q4 2020 Feb 16, 2021	BUY	$23.42 - $39.5 $85,389 - $144,017	3,646 Added 46.12%	11,552 $396,000
Q3 2020 Nov 16, 2020	SELL	$21.55 - $33.92 $315,901 - $497,233	-14,659 Reduced 64.96%	7,906 $243,000
Q2 2020 Aug 14, 2020	BUY	$30.8 - $32.99 $695,002 - $744,419	22,565 New	22,565 $700,000

Others Institutions Holding RPTX

# of Institutions

Shares Held

35.4M

Call Options Held

50K

Put Options Held

300

View Full List

About Repare Therapeutics Inc.

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $118M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

More about RPTX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account